- Home
- CLDX vs ENVX Comparison
CLDX vs ENVX Comparison
Compare CLDX & ENVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLDX
- ENVX
- Stock Information
- Founded
- CLDX 1983
- ENVX 2006
- Country
- CLDX United States
- ENVX United States
- Employees
- CLDX N/A
- ENVX N/A
- Industry
- CLDX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- ENVX Industrial Machinery/Components
- Sector
- CLDX Health Care
- ENVX Miscellaneous
- Exchange
- CLDX Nasdaq
- ENVX Nasdaq
- Market Cap
- CLDX 1.8B
- ENVX 1.6B
- IPO Year
- CLDX 2008
- ENVX N/A
- Fundamental
- Price
- CLDX $25.14
- ENVX $11.05
- Analyst Decision
- CLDX Buy
- ENVX Strong Buy
- Analyst Count
- CLDX 7
- ENVX 11
- Target Price
- CLDX $64.83
- ENVX $20.82
- AVG Volume (30 Days)
- CLDX 914.2K
- ENVX 5.8M
- Earning Date
- CLDX 02-24-2025
- ENVX 02-18-2025
- Dividend Yield
- CLDX N/A
- ENVX N/A
- EPS Growth
- CLDX N/A
- ENVX N/A
- EPS
- CLDX N/A
- ENVX N/A
- Revenue
- CLDX $9,976,000.00
- ENVX $20,738,000.00
- Revenue This Year
- CLDX N/A
- ENVX $195.43
- Revenue Next Year
- CLDX N/A
- ENVX $76.44
- P/E Ratio
- CLDX N/A
- ENVX N/A
- Revenue Growth
- CLDX 128.55
- ENVX 1429.35
- 52 Week Low
- CLDX $22.93
- ENVX $5.70
- 52 Week High
- CLDX $53.18
- ENVX $18.68
- Technical
- Relative Strength Index (RSI)
- CLDX 47.58
- ENVX 63.98
- Support Level
- CLDX $24.14
- ENVX $7.54
- Resistance Level
- CLDX $25.83
- ENVX $11.47
- Average True Range (ATR)
- CLDX 1.23
- ENVX 0.78
- MACD
- CLDX 0.02
- ENVX 0.28
- Stochastic Oscillator
- CLDX 48.41
- ENVX 93.69
About CLDX Celldex Therapeutics Inc.
Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. Its pipeline products are Varlilumab, CDX-301, CDX-1140,CDX-0159/Anti-KIT Program, and CDX-527.
About ENVX Enovix Corporation
Enovix Corp is engaged in the business of advanced silicon-anode lithium-ion battery development and production. It is also developing its 3D cell technology and production process for the electric vehicle and energy storage markets to help enable the widespread utilization of renewable energy.